Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33โ37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
PERT Update: Addressing Current Shortages
At Neuroendocrine Cancer UK, we have been actively collaborating with our charity partners to tackle the urgent need to resolve the ongoing shortages of Pancreatic Enzyme Replacement Therapy (PERT). Our joint efforts have resulted in significant strides towards...
June Highlights
Thanks to you, this is what we have been able to achieve this month. - - ๐ June Highlights! ๐ ๐ We've been working...
Announcing the 2024 Pump-Priming Grant Winner
As part of our โAdvancing Neuroendocrine Cancer Researchโ campaign, and in collaboration with the United Kingdom & Ireland Neuroendocrine Tumour Society (UKINETS) we are funding one pump-priming grant in 2024. This grant aims to provide pump-priming funds to...